166 related articles for article (PubMed ID: 31325544)
21. Design and synthesis of a monocyclic derivative as a selective ACC1 inhibitor by chemical modification of biphenyl ACC1/2 dual inhibitors.
Mizojiri R; Tomita D; Sasaki M; Satoh Y; Yamamoto Y; Sumi H; Maezaki H
Bioorg Med Chem; 2021 Apr; 35():116056. PubMed ID: 33607488
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Biological Evaluation and Molecular Docking Studies of Piperidinylpiperidines and Spirochromanones Possessing Quinoline Moieties as Acetyl-CoA Carboxylase Inhibitors.
Huang T; Sun J; Wang Q; Gao J; Liu Y
Molecules; 2015 Sep; 20(9):16221-34. PubMed ID: 26370948
[TBL] [Abstract][Full Text] [Related]
23.
Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
Front Immunol; 2018; 9():495. PubMed ID: 29675017
[No Abstract] [Full Text] [Related]
24. Human acetyl-CoA carboxylase 1 gene: presence of three promoters and heterogeneity at the 5'-untranslated mRNA region.
Mao J; Chirala SS; Wakil SJ
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7515-20. PubMed ID: 12810950
[TBL] [Abstract][Full Text] [Related]
25. Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis.
Scott KE; Wheeler FB; Davis AL; Thomas MJ; Ntambi JM; Seals DF; Kridel SJ
PLoS One; 2012; 7(1):e29761. PubMed ID: 22238651
[TBL] [Abstract][Full Text] [Related]
26. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.
Harada N; Oda Z; Hara Y; Fujinami K; Okawa M; Ohbuchi K; Yonemoto M; Ikeda Y; Ohwaki K; Aragane K; Tamai Y; Kusunoki J
Mol Cell Biol; 2007 Mar; 27(5):1881-8. PubMed ID: 17210641
[TBL] [Abstract][Full Text] [Related]
27. Acetyl-CoA carboxylase inhibitors attenuate WNT and Hedgehog signaling and suppress pancreatic tumor growth.
Petrova E; Scholz A; Paul J; Sturz A; Haike K; Siegel F; Mumberg D; Liu N
Oncotarget; 2017 Jul; 8(30):48660-48670. PubMed ID: 27750213
[TBL] [Abstract][Full Text] [Related]
28. Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence.
Rios Garcia M; Steinbauer B; Srivastava K; Singhal M; Mattijssen F; Maida A; Christian S; Hess-Stumpp H; Augustin HG; Müller-Decker K; Nawroth PP; Herzig S; Berriel Diaz M
Cell Metab; 2017 Dec; 26(6):842-855.e5. PubMed ID: 29056512
[TBL] [Abstract][Full Text] [Related]
29. Structural basis for regulation of human acetyl-CoA carboxylase.
Hunkeler M; Hagmann A; Stuttfeld E; Chami M; Guri Y; Stahlberg H; Maier T
Nature; 2018 Jun; 558(7710):470-474. PubMed ID: 29899443
[TBL] [Abstract][Full Text] [Related]
30. The ACC1 gene, encoding acetyl-CoA carboxylase, is essential for growth in Ustilago maydis.
Bailey A; Keon J; Owen J; Hargreaves J
Mol Gen Genet; 1995 Nov; 249(2):191-201. PubMed ID: 7500941
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of 4-phenoxy-phenyl isoxazoles as novel acetyl-CoA carboxylase inhibitors.
Wu X; Yu Y; Huang T
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1236-1247. PubMed ID: 34100310
[TBL] [Abstract][Full Text] [Related]
32. A yeast acetyl coenzyme A carboxylase mutant links very-long-chain fatty acid synthesis to the structure and function of the nuclear membrane-pore complex.
Schneiter R; Hitomi M; Ivessa AS; Fasch EV; Kohlwein SD; Tartakoff AM
Mol Cell Biol; 1996 Dec; 16(12):7161-72. PubMed ID: 8943372
[TBL] [Abstract][Full Text] [Related]
33. Reciprocal regulation of acetyl-CoA carboxylase 1 and senescence in human fibroblasts involves oxidant mediated p38 MAPK activation.
Marmisolle I; Martínez J; Liu J; Mastrogiovanni M; Fergusson MM; Rovira II; Castro L; Trostchansky A; Moreno M; Cao L; Finkel T; Quijano C
Arch Biochem Biophys; 2017 Jan; 613():12-22. PubMed ID: 27983949
[TBL] [Abstract][Full Text] [Related]
34. Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication.
Spencer CM; Schafer XL; Moorman NJ; Munger J
J Virol; 2011 Jun; 85(12):5814-24. PubMed ID: 21471234
[TBL] [Abstract][Full Text] [Related]
35. (4-Piperidinyl)-piperazine: a new platform for acetyl-CoA carboxylase inhibitors.
Chonan T; Oi T; Yamamoto D; Yashiro M; Wakasugi D; Tanaka H; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
Bioorg Med Chem Lett; 2009 Dec; 19(23):6645-8. PubMed ID: 19853443
[TBL] [Abstract][Full Text] [Related]
36. ACC1 is overexpressed in liver cancers and contributes to the proliferation of human hepatoma Hep G2 cells and the rat liver cell line BRL 3A.
Ye B; Yin L; Wang Q; Xu C
Mol Med Rep; 2019 May; 19(5):3431-3440. PubMed ID: 30816537
[TBL] [Abstract][Full Text] [Related]
37. Acetyl-CoA carboxylase-a as a novel target for cancer therapy.
Wang C; Rajput S; Watabe K; Liao DF; Cao D
Front Biosci (Schol Ed); 2010 Jan; 2(2):515-26. PubMed ID: 20036965
[TBL] [Abstract][Full Text] [Related]
38. Phylogeny and molecular evolution of the Acc1 gene within the StH genome species in Triticeae (Poaceae).
Fan X; Sha LN; Wang XL; Zhang HQ; Kang HY; Wang Y; Zhou YH
Gene; 2013 Oct; 529(1):57-64. PubMed ID: 23911302
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of acetyl-CoA carboxylases by soraphen A prevents lipid accumulation and adipocyte differentiation in 3T3-L1 cells.
Cordonier EL; Jarecke SK; Hollinger FE; Zempleni J
Eur J Pharmacol; 2016 Jun; 780():202-8. PubMed ID: 27041646
[TBL] [Abstract][Full Text] [Related]
40. Targeting acetyl-CoA carboxylase 1 for cancer therapy.
Yu Y; Nie Q; Wang Z; Di Y; Chen X; Ren K
Front Pharmacol; 2023; 14():1129010. PubMed ID: 36843935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
